AR015771A1 - Proceso para la preparacion de r-(+)-6-carboxamido-3-n-metilamino-1,2,3,4-tetrahidrocarbazol, compuestos intermediarios y el uso del acido l-piroglutamico. - Google Patents

Proceso para la preparacion de r-(+)-6-carboxamido-3-n-metilamino-1,2,3,4-tetrahidrocarbazol, compuestos intermediarios y el uso del acido l-piroglutamico.

Info

Publication number
AR015771A1
AR015771A1 ARP990101781A ARP990101781A AR015771A1 AR 015771 A1 AR015771 A1 AR 015771A1 AR P990101781 A ARP990101781 A AR P990101781A AR P990101781 A ARP990101781 A AR P990101781A AR 015771 A1 AR015771 A1 AR 015771A1
Authority
AR
Argentina
Prior art keywords
carboxamido
preparation
tetrahydrocarbazol
methylamin
pyroglutamic acid
Prior art date
Application number
ARP990101781A
Other languages
English (en)
Original Assignee
Vanguard Medica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanguard Medica Ltd filed Critical Vanguard Medica Ltd
Publication of AR015771A1 publication Critical patent/AR015771A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un proceso para la preparacion de r-(+)-6-carboxamido-3-N-metilamino-1,2,3,4-tetrahidrocarbazol, que comprende el paso de resolver una mezcla enantioméricade un compuesto de formula I; compuestos intermediarios y uso del ácido L-piroglutámico, y quese emplea en la resolucion de una mezcla enantiomérica de uncompuesto de la formula I.
ARP990101781A 1998-04-16 1999-04-16 Proceso para la preparacion de r-(+)-6-carboxamido-3-n-metilamino-1,2,3,4-tetrahidrocarbazol, compuestos intermediarios y el uso del acido l-piroglutamico. AR015771A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808069.0A GB9808069D0 (en) 1998-04-16 1998-04-16 Novel processes

Publications (1)

Publication Number Publication Date
AR015771A1 true AR015771A1 (es) 2001-05-16

Family

ID=10830430

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101781A AR015771A1 (es) 1998-04-16 1999-04-16 Proceso para la preparacion de r-(+)-6-carboxamido-3-n-metilamino-1,2,3,4-tetrahidrocarbazol, compuestos intermediarios y el uso del acido l-piroglutamico.

Country Status (34)

Country Link
US (1) US6359146B1 (es)
EP (1) EP1070051B1 (es)
JP (1) JP4756740B2 (es)
KR (1) KR100612183B1 (es)
CN (1) CN1200931C (es)
AR (1) AR015771A1 (es)
AU (1) AU3437099A (es)
BR (1) BR9909627A (es)
CA (1) CA2328345C (es)
CY (1) CY1116418T1 (es)
CZ (1) CZ297303B6 (es)
DK (1) DK1070051T3 (es)
EA (1) EA004586B1 (es)
EE (1) EE05156B1 (es)
ES (1) ES2541432T3 (es)
GB (1) GB9808069D0 (es)
HK (1) HK1037615A1 (es)
HR (1) HRP20000683B1 (es)
HU (1) HU230559B1 (es)
ID (1) ID26783A (es)
IL (1) IL139017A (es)
MX (1) MXPA00010127A (es)
MY (1) MY126530A (es)
NO (1) NO317883B1 (es)
PL (1) PL210864B1 (es)
PT (1) PT1070051E (es)
SI (1) SI1070051T1 (es)
SK (1) SK286425B6 (es)
TR (1) TR200100142T2 (es)
TW (1) TWI255812B (es)
UA (1) UA70943C2 (es)
WO (1) WO1999054302A1 (es)
YU (1) YU62800A (es)
ZA (1) ZA200006303B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010073253A1 (en) * 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
WO2011095803A1 (en) * 2010-02-02 2011-08-11 Generics [Uk] Limited Hplc method for analyzing frovatriptan
EP2816030A1 (en) 2013-06-20 2014-12-24 Duke Chem, S. A. Process for the preparation of frovatriptan and its enantiomer
CN103421855B (zh) * 2013-08-13 2016-04-13 凯莱英医药集团（天津）股份有限公司 一种制备琥珀酸夫罗曲坦关键中间体的方法
CN104529871A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种琥珀酸呋罗曲坦的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2528267A (en) * 1950-10-31 Eobeet j
NL7514300A (nl) * 1975-12-09 1977-06-13 Stamicarbon Werkwijze voor de bereiding van optisch actief fenylglycineamide.
JPS6259274A (ja) * 1985-05-29 1987-03-14 Sumitomo Pharmaceut Co Ltd 光学活性なフエニルセリン誘導体の製造方法
US5827871A (en) 1991-06-26 1998-10-27 Smithkline Beecham Plc Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof
GB9113802D0 (en) 1991-06-26 1991-08-14 Smithkline Beecham Plc Medicaments
US5616603A (en) 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
IL110255A (en) * 1993-07-16 1998-12-06 Merck & Co Inc Creation and resolution of 2 tert-butylcarboxamidopiprazine
JPH07229341A (ja) * 1994-02-15 1995-08-29 Takero Mori 観音開き扉用ロック
US5618948A (en) 1995-05-26 1997-04-08 Smithkline Beecham P.L.C. Process for preparing an enantiomer of a carbazole derivative
US5917054A (en) 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists

Also Published As

Publication number Publication date
EE05156B1 (et) 2009-04-15
HUP0101445A3 (en) 2002-12-28
EP1070051B1 (en) 2015-06-03
SK15182000A3 (sk) 2001-06-11
ID26783A (id) 2001-02-08
HRP20000683A2 (en) 2001-04-30
EA200001080A1 (ru) 2001-06-25
CN1200931C (zh) 2005-05-11
CZ20003823A3 (cs) 2001-08-15
PL343528A1 (en) 2001-08-27
JP4756740B2 (ja) 2011-08-24
SI1070051T1 (sl) 2015-07-31
HRP20000683B1 (hr) 2016-01-01
HK1037615A1 (en) 2002-02-15
PL210864B1 (pl) 2012-03-30
EP1070051A1 (en) 2001-01-24
PT1070051E (pt) 2015-08-24
CY1116418T1 (el) 2017-02-08
IL139017A0 (en) 2001-11-25
HUP0101445A2 (hu) 2001-09-28
ES2541432T3 (es) 2015-07-20
WO1999054302A1 (en) 1999-10-28
AU3437099A (en) 1999-11-08
TWI255812B (en) 2006-06-01
IL139017A (en) 2005-08-31
EA004586B1 (ru) 2004-06-24
MY126530A (en) 2006-10-31
KR20010042661A (ko) 2001-05-25
KR100612183B1 (ko) 2006-08-16
CZ297303B6 (cs) 2006-11-15
NO20005158L (no) 2000-10-31
TR200100142T2 (tr) 2001-07-23
US6359146B1 (en) 2002-03-19
CA2328345A1 (en) 1999-10-28
CA2328345C (en) 2010-12-07
BR9909627A (pt) 2001-11-06
YU62800A (sh) 2002-11-15
ZA200006303B (en) 2001-05-30
CN1305460A (zh) 2001-07-25
EE200000597A (et) 2002-04-15
NO317883B1 (no) 2004-12-27
UA70943C2 (uk) 2004-11-15
HU230559B1 (hu) 2016-12-28
DK1070051T3 (en) 2015-07-06
GB9808069D0 (en) 1998-06-17
NO20005158D0 (no) 2000-10-13
JP2002512227A (ja) 2002-04-23
SK286425B6 (sk) 2008-09-05
MXPA00010127A (es) 2002-08-06

Similar Documents

Publication Publication Date Title
MX9302214A (es) Derivados de taxol y proceso para su preparacion
BR0012434A (pt) Composto, processo para a preparação do mesmo, uso de um composto, composição farmacêutica.
EA199900580A1 (ru) Фармацевтические производные аминофосфоновой кислоты
ES2081636T3 (es) Preparacion de piperidinas sustituidas.
PT97796A (pt) Processo para a preparacao de piperidinas substituidas
BR9708233A (pt) Processo para sìntese de um composto e composto.
BR1100379A (pt) Composto, uso de um composto, preparação farmacêutica e processo para preparação de um composto
AR015771A1 (es) Proceso para la preparacion de r-(+)-6-carboxamido-3-n-metilamino-1,2,3,4-tetrahidrocarbazol, compuestos intermediarios y el uso del acido l-piroglutamico.
BR9507381A (pt) Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos
NO20016151L (no) Fremstilling av substituerte piperidin-4-oner
BR9400016A (pt) Processo para preparação de compostos, e compostos
BR8803402A (pt) Poliisocianatos aromaticos,processo para a sua preparacao e utilizacao
ES2038740T3 (es) Procedimiento de obtencion de compuesos guanidicos que comprenden un ion tetrafenilborato sustituido.
PT91873A (pt) Processo para a preparacao de composicoes farmaceuticas contendo acidos oxapenem-3-carboxilicos estaveis uteis como inibidores de beta-lactamase
AR004165A1 (es) Una sal de diclavulanato de bis-(2-dialquilaminoalquil)-eter; un procedimiento para preparar la misma; y una composicion farmaceutica que la contiene
BR0210512A (pt) Processo de decomposição papa o ácido (r)-(-)-2-hidroxi-2-(2-clorofenil) acético
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
BR9405186A (pt) Processo para a preparação de 2,4,5-tribromopirrol-3-carbonitrila
FI961423A (fi) Antrasykliinidisakkaridit, menetelmä niiden valmistamiseksi sekä niitä sisältävät farmaseuttiset koostumukset
ES2103553T3 (es) Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
EA200100241A1 (ru) Способ синтеза экзохелинов (варианты)
ES2105569T3 (es) Nuevos analogos de metabolitos de acidos grasos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
IT1270834B (it) Disolfuro chinolico
DK0462556T3 (da) Hypotriglyceridæmisk anvendelse af bis(3,5-di-alkyl-4-hydroxyphenylthio)methaner

Legal Events

Date Code Title Description
FG Grant, registration